Efficacy of adavosertib therapy against anaplastic thyroid cancer.

Lu, Yu-Ling; Huang, Yu-Tung; Wu, Ming-Hsien; Chou, Ting-Chao; J Wong, Richard; Lin, Shu-Fu

Lu, Yu-Ling; Huang, Yu-Tung; Wu, Ming-Hsien; Chou, Ting-Chao; J Wong, Richard; Lin, Shu-Fu.

Afiliación

Lu YL; Department of Internal Medicine, New Taipei Municipal TuCheng Hospital, New Taipei City, Taiwan.
Huang YT; Department of Internal Medicine, Chang Gung Memorial Hospital, Taoyuan, Taiwan.
Wu MH; Chang Gung University, Taoyuan, Taiwan.
Chou TC; Center for Big Data Analytics and Statistics, Chang Gung Memorial Hospital, Taoyuan, Taiwan.
J Wong R; Department of Internal Medicine, New Taipei Municipal TuCheng Hospital, New Taipei City, Taiwan.
Lin SF; Department of Internal Medicine, Chang Gung Memorial Hospital, Taoyuan, Taiwan.

Endocr Relat Cancer ; 28(5): 311-324, 2021 04 29.

Article en En | MEDLINE | ID: mdl-33769310

Asunto(s)

Carcinoma Anaplásico de Tiroides; Neoplasias de la Tiroides; Animales; Línea Celular Tumoral; Humanos; Ratones; Pirazoles/efectos adversos; Pirimidinonas; Sorafenib; Carcinoma Anaplásico de Tiroides/tratamiento farmacológico; Neoplasias de la Tiroides/inducido químicamente; Neoplasias de la Tiroides/tratamiento farmacológico

Palabras clave

CompuSyn; Wee1; adavosertib; anaplastic thyroid cancer; combination index; combination therapy; dabrafenib; lenvatinib; sorafenib; synergy; trametinib

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Neoplasias de la Tiroides / Carcinoma Anaplásico de Tiroides Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Endocr Relat Cancer Asunto de la revista: ENDOCRINOLOGIA / NEOPLASIAS Año: 2021 Tipo del documento: Article País de afiliación: Taiwán

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google